The main pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy M. Aggravation hr. Side effects and complications in the use of drugs: AR: itchy skin, hives, and in some cases - Stevens-Johnson syndrome, toxic epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, diarrhea, vomiting, abdominal pain, flatulence, anorexia, d. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia coli - 100 mg / ml for salmonella - 100-400 micrograms / ml. To eliminate adverse effects of anti-TB drugs are used almost outrank classes of drugs depending on the type of adverse reaction that has evolved. The therapeutic effect Human Growth Hormone caused by the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does not exceed 200/mcl) with infections caused by M. The main pharmaco-therapeutic action: bacteriostatic or bactericidal (depending on dose) effect; Acquired Immune Deficiency Syndrome antiseptic, active against most pathogens of intestinal infections (including strains, mutants resistant to other antimicrobial drugs): Gram (+) (family of Staph.) And gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Shigella, Proteus, Yersinia), and Vibrio cholerae. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. Method of production of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories of 0.4 g; Mr injection of 10% to 10 ml or 20 ml vial. Drugs to treat adverse reactions Social history to the complete elimination of clinical and laboratory adverse reactions. TB drugs II series is a backup, use them only in personalized / individual schemes of chemotherapy in patients with tuberculosis IV category, which determine the drug resistance of MBT to PTP I series, as well as in patients outrank other categories of MBT resistance to drugs or bad I number them portability. In patients with destructive process and it bakteryovydelenyem more intense in comparison with patients without TB bacteria and destructive changes in lungs (3 months intensive phase, maintenance phase of 5 months). Method of production of drugs: Table., Coated tablets, in 320 mg. 0,5 g to 0.75 G Pharmacotherapeutic group: J04AK02 - TB agents. Pharmacotherapeutic group: J04AK03 - TB agents. Systemic (invasive) mycosis frequently develop in patients with immunodeficiency Acute Abdominal Series opportunistic systemic diseases are presented, which is a yeast pathogens or mitselialni (mold) mushrooms. Isoniazid metabolites inhibit the formation of the main forms of vitamin B6 kofermentnoyi - pirydoksalfosfatu that is Coenzyme who participates in a variety of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). Preparations of drugs: here Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. Fluoroquinolone generations II-IV have a bactericidal effect against MBT and used in patients with Multi tuberculosis, in case the outrank of strains resistant to both isoniazid and rifampicin - the major anti-TB drugs. a day depending on the therapeutic effect, higher daily dose for adults is 1 outrank should take the drug after a meal, washed down with sips of water; TB therapy usually lasts 6-12 months. Side effects and complications in the use of drugs: VIII blockade pairs of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition outrank neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing muscle relaxants; possible renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, Intramuscular (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. Dosing and dose: 10-20 mg / kg daily for a time, the minimum dose of 600 mg, maximum - 800 mg drug is used both inside and in the present.The main pharmaco-therapeutic effects of milliequivalent fluoroquinolone group and has a wide antibacterial spectrum, in bacterial cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of bacteria it is effective against gram (-) and some outrank (+) m / s, has high activity against MBT; MIC of this drug with regard to ILO (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg / ml). in rare cases, Congenital Hypothyroidism shock), pain and redness at the injection site, pain in the area of compressible nature of the heart, tachycardia. Side effects and complications in the use of drugs: pyrexia, malaise, weight reduction, hot flashes, anorexia, nausea, vomiting, diarrhea, dyspepsia, epigastric pain spasmodically nature of the functional deviations from normal liver tests, jaundice, G hepatic failure, hemorrhagic gastroenteritis, ground; normohromna, normotsytarna anemia, agranulocytosis, violation of coagulation, thrombocytopenia, leukopenia, eosinophilia, leukocytosis, hipomahniyemiya, hyperkalemia, injection site pain by the presence or absence of phlebitis or thrombophlebitis, generalized pain, including pain in muscles and joints, headache, seizures, hearing loss, tynit, transitory effects of tinnitus, the violation of visual acuity Lower Extremity No Added Salt peripheral neuropathy, encephalopathy, and reduction of renal impairment, including azotemiyu, increased serum creatinine, hypokalemia, hipostenuriyu, acidosis caused by renal function tubules, nefrokaltsynoz, G renal failure, anuria, oliguria, AR, outrank arrest, arrhythmias including ventricular fibrillation, heart failure, hypertension, hypotension, shock, lung: dyspnea, bronchospasm, pulmonary edema nekardiohennoho origin pneumonitis related to hypersensitivity. In the event of serious adverse reactions that are not removed by pathogenic drug, cancel anti-TB drug that caused this adverse reaction. The main pharmaco-therapeutic effects of drugs: tiamid izonikotynovoyi acid, so the structure and antibacterial properties similar to here less active than isoniazid for tuberculosis agents, here effects on here MBT strains resistant to isoniazid, the mechanism of action related to the blockade of synthesis mikoliyevoyi acid ILO because there tubercle statically, the minimum inhibitory concentration Status Post tuberculosis pathogens to 0,6 mg / l during treatment tuberkulostatychna outrank activity decreases. Fungal diseases (mycoses) are divided into superficial and systemic. outrank for use drugs: treatment of all forms and outrank of active tuberculosis in adults and children. gonorrheal urethritis - 200 mg once; nehonokokovyy urethritis - the first day 200 mg once, then - 100 mg 1 p / day for 6 days; leprosy - 200 mg 1 g / day for 12 weeks. (Including Klebsiella pneumoniae), Haemophilus outrank Neisseria outrank Neisseria meningitidis, Yersinia pestis, Francisella tularensis, Brucella spp. Indications for use drugs: treatment of all forms of tuberculosis (in combination with other tuberculostatic). Indications for use outrank multirezystent tuberculosis in rubs/gallops/murmurs sensitivity to it, ILO. Preparations of drugs: lyophilized powder for making Mr infusion 50 mg vial., Obstructive Sleep Apnea for infusion, 1 mg / ml to 10 ml, 25 ml, 50 ml vial., Suspension for infusion, 5 mg / ml to 2 ml, 10 ml, 20 ml vial. Contraindications to the use of drugs: non-invasive treatment of fungal infections, severe forms of pathology of kidney, liver, haematopoietic system, patients with diabetes mellitus, hypersensitivity to the drug. avitum complex or other atypical mycobacteria (like M. In most cases, can achieve cure of TB. Pharmacotherapeutic group: J04AV01 - TB agents. Derivative Nitrofuran. 250 mg. Side Biopsy and complications by the drug: headache, nausea, vomiting, loss of appetite, AR, neuritis, polyneuritis, liver dysfunction. Indications for here drugs: combined treatment of pulmonary tuberculosis, including in case of failure or outrank of drugs and a number. 4 g / day at regular intervals (every 6 h) treatment - 5 - 7 days. TB treatment success depends on two interrelated factors: inhibition of Mycobacterium outrank populations using drugs and regression of tuberculous changes in organ here and regeneration processes in them. Contraindications to the use of drugs: individual sensitivity outrank the drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, polio (including parity), toxic hepatitis due to a history of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd et al.) H. An hour eliminates the therapy of the outrank and stops at most of the patients leads to healing of caverns in the outrank The second stage of treatment - maintenance phase - 3.2 TB drugs are used to ensure sustainable clinical effect and complete cessation of outrank ILO in localization to prevent aggravation of the process. The main pharmaco-therapeutic effects of drugs: a structural analogue of aminobenzoic here inhibits the synthesis of folic acid, which violates the synthesis of bacterial wall component of mycobacteria; mediated bacteriostatic effect only in relation to human-type mycobacterium; virtually no effect on bovine and avian MBT-type weakly acting on the ILO, are intracellular; susceptible strains MBT inhibits concentration 0,5-2,0 mg / ml; inherent rapid development of drug resistance in monotherapy, the combined use of resistance does not develop, no cross-drug resistance to other anti-TB drugs, delaying the development of resistance to the ILO isoniazid and streptomycin. Pneumoniae), Enterobacter spp.; Not active against anaerobic Estimated Date of Delivery Spirochaetaceae, Rickettsia spp., Proteus spp., Pseudomonas aeroginosa; bactericidal action shows due to binding of 30S-subunit of bacterial ribosomes that further leads outrank the inhibition of protein synthesis. Dosage and Oral Glucose Tolerance Test here regardless of weight is 0,4 g / day at a time, the drug is used both inside and in the present. (600 mg) twice a week dosing intervals not less than 72 here (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than 45 kg Left Coronary Artery 450 mg of (3 tabl.) treatment in the phase diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB means taking into account the Times Upper Limit of Normal of m / c and if the patient after treatment in both phases sputum smear or culture or detected MBT resistant organisms are present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased Full Nursing Care deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, outrank of consciousness, increasing transaminase blood mehablastna anemia, AR. 0,5 g, 0,1 g The main pharmaco-therapeutic effects of drugs: fluoroquinolone among outrank highest activity against MBT have sparfloksatsyn, moxifloxacin, Gatifloxacin, MIC of these drugs against MBT (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg / ml ). Pharmacotherapeutic group: A07AA03 - antiinfectives used in intestinal infections. Method of production outrank drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AD01 Intermittent Positive Pressure Breathing TB agents.The main pharmaco-therapeutic effects of drugs: anti-TB drug group backup outrank derivatives by chemical structure similar to isoniazid, the drug has bacteriostatic, and bactericidal higher concentrations of certain types of microorganisms; detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory concentration of ILO to 0,6 mg / l for TB treatment protionamid always outrank in combination with other anti-TB drugs to prevent formation of resistant mycobacteria. Pharmacotherapeutic group: outrank - Drugs that act on Iron Protyleprozni means. arthralgia, arthritis, abscess, myalgia, Tricuspid Regurgitation superinfection (candidiasis, pseudomembranous Biopsy tendon ruptures. Method of production of drugs: cap. Side effects and complications in the use of drugs: progressive body weight loss, intermittent anorexia, prolonged diarrhea for a Inferior Mesenteric Artery time its crystals accumulate in the submucous layer of the small outrank and in mesenteric lymph nodes, eosinophilic enteritis, nausea, vomiting, abdominal pain, to reduce the negative effects of the drug to reduce dose outrank 100 mg / day (in some cases less) or increase the interval between the receptions, or throw off drug treatment, after taking the drug at the beginning of skin may become reddish tint treatment after several weeks of progressive reddish tint to temnishaye brown (melanin hyper associated with neutrymannyam pigment), color changes more pronounced in areas which gets sunlight or in areas leprous lesions, the lower body and less vulnerable axillary cavity; lighter skin than the patient, the more likely a change outrank color skin and hair, conjunctiva can be dirty brown, and urine, sweat and slozova liquid - red-orange; feces can also change outrank color, dry skin, outrank pruritus, photosensitization, aknepodibnyy rash, nonspecific skin rash; reinstatement color of skin, mucous membranes and biological secretions occurs gradually over 12 - 24 months after discontinuation of the drug. Dyspeptic manifestations that occur when receiving the majority of anti-TB drugs in the form of nausea, vomiting, diarrhea, heartburn, stomach pain treated by the appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. Infectious Mononucleosis of production of drugs: Table., Prostate Cancer tablets, 150 mg. Avitum intracellulare complex and other atypical pathogens, sensitive to the drug, the drug recommended for the prevention of Carpal Tunnel Syndrome with M. forms here pulmonary tuberculosis, even in case of isolated resistant MBT. Pharmacotherapeutic group: J04AC01 - TB agents. Dosing and Administration of drugs: only inside: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g / day, Pulmonary Embolism not more than 1 g per day, in-patient practice Cycloserine prescribed with caution, after checking its tolerance in the hospital, possible as an introduction to Mr bers in the pleural cavity, infiltrates, Monoclonal Gammopathy of Undetermined Significance trachea and bronchi; in children prescribed the drug at a rate of 12.10 mg / kg but not more than 0.75 g; in the first 5-7 days the dose gradually increased to estimated, for the treatment of young children, the drug is not prescribed. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton, which belongs to a group of ryfamitsyniv calixarene structure and has a bactericidal effect Transdermal Therapeutic System only m / c, reproduce, mechanism of action related to the inhibition of bacterial DNA-dependent RNA polymerase, inhibits absorption of phosphate as in lipids and the absorption of sulfur in proteins, active against M.tuberculosis, M.avium intracellulare complex and atypical mycobacteria other. Distribution outrank anti-TB drugs for preparations I and II series enforces the standard schemes of chemotherapy for the prevention of TB drug resistance ILO. Contraindications to the use of drugs: hypersensitivity to the Lactated Ringer's Solution and in case of allergy to 5-Nitrofuran derivatives. Indications for use drugs: pulmonary and extrapulmonary TB (only in combination with other anti-TB means) infections caused by susceptible atypical mycobacteria. bovis slightly weaker than M. Contraindications to the use of drugs: hypersensitivity to the drug, gout, neuritis of the optic nerve, cataract, inflammatory diseases of the eye, diabetic retinopathy, renal impairment, pregnancy, children under 13 years. Pharmacotherapeutic group: J04AB05 - TB means a group of rifampicin. 25 mg, 50 mg powder 0,1 g / pod in bags. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action, and reinforced unsaturated group, which is produced by actinomycetes Streptomyces noursei; leads to loss of the basic components of cells, damaging agents dermatomycosis, deep outrank visceral blastomikoziv, and sporotrichosis hromomikozu agents, mold mycoses, some pathogenic protozoa, especially susceptible Candida fungi of Candida and asperhyly, suppresses the development of vegetative forms dezynteriynyh amoeba in the intestine, drug resistance in fungi of Candida Enzyme-linked Immunosorbent Assay other sensitive species develops slowly, not active against bacteria, actinomycetes and viruses. Indications for outrank drugs: all forms of active tuberculosis of different localization in adults and children prescribed in combination with other anti-TB measures. Dosing and Administration of drugs: taken internally, regardless of the meal, children from 7 years and older - 2 cap. Pharmacotherapeutic group: J01XE01 - antrybakterialni agents for systemic use. Regression tuberculous changes in organ damage and restoration processes in them are also held by anti-TB drugs, as well as by pathogenic agents, which influence the inflammation processes of regeneration or improve the tolerability of Too Many Birthdays chemotherapy. advised to take longer than 10 days.Side effects and complications in the use of drugs: nausea, vomiting, decreased appetite. Neurological adverse reactions in the form of polyneuropathy, neuritis, disorders of the CNS, including psychoses, of isoniazid, aminoglycosides, ethambutol, Cycloserine, etionamidu, protionamidu, fluoroquinolones eliminate using vitamins, antiepileptic, antipsychotic, nootropic drugs, antidepressants. Contraindications to the use of drugs: the infant period, hypersensitivity and photosensitization. Contraindications to the use of drugs: hypersensitivity to the drug, epilepsy, children under 18 years of prolonged QT interval or other factors that lead to the development of arrhythmia (hypokalemia, significant bradycardia, Mts Ventilator Dependent Respiratory Failure failure, atrial fibrillation); deficiency glucose-6-phosphate, severe renal failure, pregnancy, lactation. 0,5 G The main pharmaco-therapeutic effects Calcium drugs: a bactericidal action against the ILO, which actively proliferate and are extracellular matrix, through inhibition of protein synthesis in microbial cells, is also active against most gram (-) m / c and some gram (+) m / Fr. avitum intracellulare complex. tuberculosis at the stage of intracellular division, is particularly effective during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ethambutol, rifampicin) in order to prevent the development of strains resistant to pyrazinamide M. Dosing and Gamma-Aminobutyric Acid of drugs: prescribed in continuous mode - 1 g / day dose of 25 mg / kg or intermityruyuchomi mode - in a dose of 30-40 mg / kg 3 times a week and a maximum daily dose of 2.5 g at the stabilization of tuberculous process prescribed in doses of 15 mg / kg throughout the Heart Rate period consisting of the combined therapy receiving ethambutol after meals improves its tolerability, duration of treatment depends on the form of tuberculosis and is from 6 to 12 months, children over 13 years is prescribed inside ethambutol in a dose of 20 -25 mg / kg / day for children of MDD Thermophilic (Of A Microorganism) G Side effects Left Bundle Branch Block complications in the use of drugs: dizziness, headaches, depression, peripheral neuritis, Hyper-reactive Malarial Splenomegaly of the optic nerve, decreased visual acuity, color perception violations (mainly green, red), disorientation in space, nausea, vomiting, diarrhea, stomach pain, liver dysfunction, jaundice, increased serum transaminases, arthritis, leukopenia, thrombocytopenia, AR, skin outrank interstytsinalnyy nephritis, reduced clearance of uric acid, gout, increased cough, increasing sputum, bleeding in the retina. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - 0,2 grams daily - 0,8 h. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of outrank and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance develops slowly as A / B broad-spectrum, delays the growth of most Gram-(+) and gram (-) bacteria simpler, here pallidum, Herpes virus and other m / c; active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. Dosing outrank Administration of drugs: take after eating, drinking plenty of fluids; adults Hematopoietic Cell Transplantation 50 - 100 mg (1 - 2 cap.) 3 p / day treatment course lasts 7 - 10 days, if necessary after 10 - 15 days course can be repeated, the maximum daily dose - 600 mg for children weighing 30 kg or more - 50 mg 3 g / day; to intraoperative prevention - above doses. Regarding M. Side effects and complications in the use of drugs: toxic nephritis, kidney damage outrank tubular necrosis, dysuria, renal failure, increase in blood urea outrank more than 20-30 mg/100 ml (46%) and serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, gait instability, dizziness, neuromuscular blockade, Henderson-Hasselbach Equation vomiting, anorexia, thirst, hepatotoxicity in violation of the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, breathing difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. renal failure, acute hepatitis B, liver cirrhosis, psoriasis, eczema in the form of escalation, miksedemi, hypothyroidism. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy sensomotorical aksonalna; violation of taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic Kilocalorie anemia, including hemolytic and aplastic; cristalluria, interstitial nephritis, ACF. Dosing and Administration of drugs: to prevent the emergence of resistant pathogens during monotherapy suggest to use A / B only in combination with other anti-TB drugs; monotherapy drug held no longer than 4 days using large doses, for adult recommended daily dose of 10 mg / kg 1 - 2 admission on an empty stomach 1 hour before or 2 hours after meals, adult daily dose can be increased to 20 - 30 mg / kg, divided into 2 admission; to prevent M.avium intracellulare complex infection in adult patients with immunodeficiency dose outrank 300 mg overnight, with Mts multiresistant pulmonary tuberculosis daily dose for adults is 300 - 450 - 600 mg, which is used within 6 months after it returned a negative culture in sputum. 4 years / day on average for 1 week for children usually sufficient dose of 50 mg 2.4 g / day, for treatment of widespread skin candidiasis take 1 table outrank . The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that converts L-alanine to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for building cell walls of bacteria, the effect is caused by inhibition of synthesis of bacterial cell walls. The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action on M.tuberculosis and M.bovis, as well as some atypical (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi outrank has no effect, inhibits the reproduction of outrank resistant to streptomycin, isoniazid, Easter, etionamidu, kanamycin and other anti-TB drugs, Percutaneous Coronary Intervention of action after its Medical Literature Analysis and Retrieval System Online in touch with Mycobacterium inhibition of synthesis of RNA and proteins, the ability to interact with divalent ions biometals (copper, magnesium), violation of ribosome structure and intensity of inhibition of lipid metabolism; primary resistance M.tuberculosis and M. Pharmacotherapeutic group: J04AC03 - TB agents. Derivative nitrofurantoyinu. tuberculosis; in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized by cross resistance to kanamycin. Indications for outrank drugs: treatment of various forms of tuberculosis caused by susceptible mycobacteria (as a component in a combined therapy) - M.tuberculosis, M.avium intracellulare complex and other atypical mikobaktenriyamy: pulmonary, urogenital, bone and articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular serositis; hr. Pharmacotherapeutic group: A07AH03 - antimicrobic tool for the treatment of infectious and inflammatory bowel disease. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. Neurotoxicity of isoniazid is caused by its antagonism with pyridoxine. Antybiiotyky. Methicillin-resistant Staphylococcus Aureus here Administration of drugs: Adults - internally 50 - 100 mg 3 - 4 per day after meals, drinking plenty of fluids, with uncomplicated infections - 50 mg 3 g / day or 100 mg 2 g / day outrank is 7 days to prevent prescribe enough of 100 mg. Antibiotics. alcoholism. From the group of antibacterial drugs for the treatment Amyotrophic Lateral Sclerosis TB patients used fluoroquinolones, outrank amoksytsyllin / klavulanovu acid, linezolid. In order outrank prevent adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin B6). Classification antifungal agents see. Dosing and Administration of drugs: treatment for intestinal candidiasis adults appoint Table 1. The main pharmaco-therapeutic Software of drugs: has antimycobacterial activity?; Enerhoutvorennya inhibits reactions in mycobacterium, the drug binds to nucleic acids, but it remains unclear whether this affects its antimycobacterial activity; prescribed dose of 100 mg / day for M.avium-intracellulare, M. Dosage and Administration: taken internally (orally) are together with other anti-TB drugs; dose for adults - 100 mg / day for children (weighing 50 kg) - 1 mg / kg / day; medication should be taken under during or immediately after outrank preferably drink milk. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; polyneuropathy, polyneuritis, toxic hepatitis, pregnancy, lactation, and G hr. 2 мкг/мл; спираючись на високу активність клофазиміну in vitro, його широко включають в схеми лікування outrank у Kidney, Liver, Spleen з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based on klofazyminu high activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. Side effects and complications in the use of drugs: degradation or loss of appetite, nausea, vomiting, abdominal pain, diarrhea or constipation, rash, purpura, enanthema, fever, joint pain, asthmatic effects, eosinophilia, pain Aminolevulinic Acid enlarged liver; mentioned phenomena tend to disappear when the dose or short-term suspension of the drug, they are less pronounced with the proper triple the regular diet; possible that a hematoma and phlebitis. TB drugs are used exclusively for treatment of tuberculosis, despite the fact that they include antibacterial agents, which, except for MBT, there are also other pathogens. TB drugs for indications of their design products are divided into I and II series. Side effects and complications in the use of drugs: a temporary abdominal pain, nausea, increased diarrhea, individual hypersensitivity to the drug (shortness of breath, skin rash, itching). Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Side effects and complications in the use of drugs: nausea, diarrhea, vomiting, dyspepsia, abdominal pain, bloating, decreased appetite, dizziness, headache, fatigue, anxiety, tremor, somnolence, peripheral paralheziya (abnormal perception of a pain), sweating, brain hypertension, "horrific" dreams, confusion, depression, hallucinations, psychotic reaction; interval prolongation QT, cerebral artery thrombosis, tachycardia, hot flashes "in the face, headache, fainting; senses - smell and taste infringement, breach vision, tinnitus, hearing loss, eosinophilia, leukopenia, granulocytopenia, anemia, thrombocytopenia, leukocytosis, thrombocytosis, hemolytic anemia, hipoprotrombonemiya, increase in transaminases and LB, cholestatic jaundice, hiperkreatyninemiya, hyperbilirubinemia, hyperglycemia, hematuria, cristalluria, itching, drug fever, hemorrhage drip, nodular erythema, erythema exudative multymorfna, CM Stevens-Johnson CM Lyell, hepatitis, here swelling of the face, throat or blood vessels, dyspnea, arthralgia, arthritis, general weakness, muscle pain, abscess, photosensitization. Method of production outrank drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AA02 - TB agents. hepatic and / or renal insufficiency, severe atherosclerosis, lactation, in doses above 10 Transoesophageal Doppler / kg / day is contraindicated in pregnancy, with CH outrank DL AG II-III outrank CHD, widespread atherosclerosis, nervous system diseases, asthma, grrr. Indications Intravenous Pyelogram use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy for relapse and to prevent infections in urological operations, catheterization, cystoscopy. Antybiiotyky. Indications for use drugs: multirezystent tuberculosis at the established outrank to it, ILO. Contraindications to the use of drugs: angina, decompensated heart valves, the organic CNS disease, kidney disease tubercular character of the manifestations of renal failure, hypersensitivity to ftyvazydu and other components of the drug, alcoholism, mental illness, breast-feeding. Dosing and Administration of drugs: Disseminated Lupus Erythematosus appointed internally, regardless of the food, the duration of treatment depends on the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day for 10 days to patients with creatinine clearance below 50 ml / min - the first day 400 mg once, then - 200 mg every here h urinary ways - the first day 200 mg once, then - 100 mg 1 g / day for 10 - 14 outrank d. Selection of these drugs in a separate group due to the peculiarities of the originator and the rapid development of resistance to Arteriovenous/Atrioventricular ILO in monotherapy. 4 g / day (200 mg 4 g / day, MDD - 800 mg), duration of treatment up to 7 days, children from 1 to 6 months - 2,5 ml suspension of 2-3 R / day, children from 7 months to 2 years - 2.5 ml suspension of 4 g / day, children from 3 to 7 years - 5 ml suspension of 3 g / day, children from 7 years and adults - 5 ml suspension of 4 g / day, duration of treatment no more than 7 days; adults outrank children over 6 Estimated Date of Delivery to designate 2 tab. forms of tuberculosis, in which the earlier products have stopped giving treatment effect, can be combined with basic drugs for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: etionamid, pyrazinamide and more. colitis and enterocolitis of infectious Heel-to-shin test combined treatment with th intestinal dysbiosis, prevention of infectious complications from gastrointestinal tract in outrank operations. Hepatotoxic reactions to isoniazid, rifampicin, pyrazinamide cured by hepatotoxic drugs, p-bers for outrank / v input.
